These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

141 related items for PubMed ID: 35885858

  • 1. Incidence and Risk of Anti-Resorptive Agent-Related Osteonecrosis of the Jaw after Tooth Extraction: A Retrospective Study.
    Shimizu R, Sukegawa S, Sukegawa Y, Hasegawa K, Ono S, Nakamura T, Fujimura A, Fujisawa A, Nakano K, Takabatake K, Kawai H, Nagatsuka H, Furuki Y.
    Healthcare (Basel); 2022 Jul 18; 10(7):. PubMed ID: 35885858
    [Abstract] [Full Text] [Related]

  • 2. Antiresorptive agent-related osteonecrosis of the jaw risk in cancer patients before bone-modifying agent therapy: A retrospective study of 511 patients.
    Kanno C, Kojima M, Tezuka Y, Yaginuma S, Kanaya Y, Kaneko T.
    Bone; 2023 Dec 18; 177():116892. PubMed ID: 37689127
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Antiresorptive Agent-Related Osteonecrosis of the Jaw (ARONJ): A Twist of Fate in the Bone.
    Shibahara T.
    Tohoku J Exp Med; 2019 Feb 18; 247(2):75-86. PubMed ID: 30713280
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Single-center analysis of antiresorptive agent-related osteonecrosis of the jaw in lung cancer patients.
    Okamura M, Fujita K, Yamamoto Y, Kanai O, Nakatani K, Horimoto K, Hashimoto M, Sawai S, Shimosato M, Yoshida K, Mio T.
    Asia Pac J Clin Oncol; 2020 Dec 18; 16(6):380-384. PubMed ID: 32893984
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Incidence of antiresorptive agent-related osteonecrosis of the jaw: A multicenter retrospective epidemiological study in Hyogo Prefecture, Japan.
    Nashi M, Kishimoto H, Kobayashi M, Tachibana A, Suematsu M, Fujiwara S, Ota Y, Hashitani S, Shibatsuji T, Nishida T, Fujimura K, Furudoi S, Ishida Y, Ishii S, Fujita T, Iwai S, Shigeta T, Harada T, Miyai D, Takeda D, Akashi M, Noguchi K, Takenobu T.
    J Dent Sci; 2023 Jul 18; 18(3):1156-1163. PubMed ID: 37404599
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Incidence of Antiresorptive Agent-Related Osteonecrosis of the Jaw in Urologic Cancers].
    Kawanishi H, Yokozeki H, Hoshiyama A, Watanabe H, Funahashi Y, Fujiwara M, Takashima Y, Shintani M, Yui S, Okumura K.
    Hinyokika Kiyo; 2022 Jan 18; 68(1):1-6. PubMed ID: 35114759
    [Abstract] [Full Text] [Related]

  • 19. Does inflammatory dental disease affect the development of medication-related osteonecrosis of the jaw in patients using high-dose bone-modifying agents?
    Ueda N, Nakashima C, Aoki K, Shimotsuji H, Nakaue K, Yoshioka H, Kurokawa S, Imai Y, Kirita T.
    Clin Oral Investig; 2021 May 18; 25(5):3087-3093. PubMed ID: 33057886
    [Abstract] [Full Text] [Related]

  • 20. Predictive factors for refractory stage I and II anti-resorptive agent-related osteonecrosis of the jaw.
    Shimizu T, Kim M, Dam TT, Kurihara J, Ogawa M, Makiguchi T, Yokoo S.
    Oral Radiol; 2022 Apr 18; 38(2):240-251. PubMed ID: 34218422
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.